EA201790831A1 - Противовирусное действие наразина в корме для свиней - Google Patents

Противовирусное действие наразина в корме для свиней

Info

Publication number
EA201790831A1
EA201790831A1 EA201790831A EA201790831A EA201790831A1 EA 201790831 A1 EA201790831 A1 EA 201790831A1 EA 201790831 A EA201790831 A EA 201790831A EA 201790831 A EA201790831 A EA 201790831A EA 201790831 A1 EA201790831 A1 EA 201790831A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pitted
pigs
feed
composition
weaned piglets
Prior art date
Application number
EA201790831A
Other languages
English (en)
Other versions
EA031870B1 (ru
Inventor
Томас Алан Марстеллер
Джейн Грэнвилль Оуэнс
Кристофер Лей Пулс
Мэтью Джон Риттер
Келли Шерн Розенкранс
Томас Эдмунд Уэбер
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA201790831A1 publication Critical patent/EA201790831A1/ru
Publication of EA031870B1 publication Critical patent/EA031870B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Настоящее изобретение относится к композиции для ослабления вирусных инфекций у поросят-отъемышей. Композиция содержит простой полиэфирный ионофор наразин и доставляется поросятам-отъемышам в перорально приемлемой форме. Композиция является эффективной для снижения выделения вируса и тяжести диареи после воздействия вируса эпизоотической диареи свиней (ЭДС) на поросят-отъемышей.
EA201790831A 2014-11-13 2015-11-10 Противовирусное действие наразина в корме для свиней EA031870B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462079159P 2014-11-13 2014-11-13
PCT/US2015/059848 WO2016077282A1 (en) 2014-11-13 2015-11-10 Antiviral effects of narasin in swine feed

Publications (2)

Publication Number Publication Date
EA201790831A1 true EA201790831A1 (ru) 2017-09-29
EA031870B1 EA031870B1 (ru) 2019-03-29

Family

ID=54782806

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201790831A EA031870B1 (ru) 2014-11-13 2015-11-10 Противовирусное действие наразина в корме для свиней

Country Status (17)

Country Link
US (2) US20170296504A1 (ru)
EP (1) EP3217971B1 (ru)
JP (1) JP6276469B2 (ru)
KR (1) KR101929141B1 (ru)
CN (1) CN107106534B (ru)
AU (1) AU2015346616B2 (ru)
BR (1) BR112017006307A2 (ru)
CA (1) CA2963476C (ru)
CL (1) CL2017001207A1 (ru)
EA (1) EA031870B1 (ru)
ES (1) ES2754354T3 (ru)
MX (1) MX2017006264A (ru)
NZ (1) NZ730374A (ru)
PL (1) PL3217971T3 (ru)
PT (1) PT3217971T (ru)
TW (1) TWI656872B (ru)
WO (1) WO2016077282A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000012325A1 (it) * 2020-05-26 2021-11-26 Blueprint Pharma Srl Metotrexato per l’uso nel trattamento di infezioni virali in animali da allevamento
WO2021240375A1 (en) * 2020-05-26 2021-12-02 Blueprint Pharma S.R.L. Methotrexate for use in the pharmaceutical or veterinary prevention and/or treatment of viral infections
CN112843043B (zh) * 2021-02-20 2023-03-14 华中农业大学 盐霉素在制备抗冠状病毒药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038384A (en) 1974-06-10 1977-07-26 Eli Lilly And Company Antibiotic a-28086 and process for production thereof
US3995027A (en) * 1975-06-04 1976-11-30 Eli Lilly And Company Anti-viral method in animals
US4174404A (en) * 1977-10-20 1979-11-13 Eli Lilly And Company Deoxynarasin antibiotics
US4309504A (en) 1980-01-28 1982-01-05 Eli Lilly And Company Process for preparing narasin
US4342829A (en) 1981-05-06 1982-08-03 Eli Lilly And Company Process for preparing narasin
US4824829A (en) * 1984-08-15 1989-04-25 American Cyanamid Company Non-dusting antibiotic, anticoccidial premix compositions and a process for their manufacture
AU682354B2 (en) * 1993-04-29 1997-10-02 Cultor Ltd. Compositions for administration to animals with coccidiosis
US5834473A (en) * 1993-04-29 1998-11-10 Cultor, Ltd. Method for treating coccidiosis
UA78486C2 (ru) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиция для перорального введения птицам и животным для лечения или снижения риска инфекции пищеварительного тракта (варианты), ее применение (варианты) и способ лечения или снижения риска инфекции пищеварительного тракта (варианты)
KR101140582B1 (ko) * 2009-10-09 2012-05-09 주식회사 옵티팜솔루션 음양곽 추출물을 포함하는 돼지유행성설사병 예방 또는 치료용 조성물
RU2675360C2 (ru) * 2013-02-08 2018-12-19 Луода Фарма Лимитед Способы лечения местных микробных инфекций

Also Published As

Publication number Publication date
EP3217971A1 (en) 2017-09-20
PT3217971T (pt) 2019-11-20
JP6276469B2 (ja) 2018-02-07
CN107106534B (zh) 2020-01-21
ES2754354T3 (es) 2020-04-17
US20170296504A1 (en) 2017-10-19
EA031870B1 (ru) 2019-03-29
AU2015346616A1 (en) 2017-04-13
AU2015346616B2 (en) 2018-03-01
MX2017006264A (es) 2017-08-14
KR20170066622A (ko) 2017-06-14
CA2963476A1 (en) 2016-05-19
WO2016077282A1 (en) 2016-05-19
TWI656872B (zh) 2019-04-21
KR101929141B1 (ko) 2018-12-13
BR112017006307A2 (pt) 2017-12-12
US20220265597A1 (en) 2022-08-25
CN107106534A (zh) 2017-08-29
NZ730374A (en) 2018-10-26
TW201628611A (zh) 2016-08-16
JP2017536345A (ja) 2017-12-07
PL3217971T3 (pl) 2020-03-31
CA2963476C (en) 2019-05-21
CL2017001207A1 (es) 2018-01-12
EP3217971B1 (en) 2019-09-11

Similar Documents

Publication Publication Date Title
CL2016002751A1 (es) Compuestos y composiciones como agonistas del receptor tipo toll 7.
EA201791460A1 (ru) N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения
CL2016002877A1 (es) Compuestos de 2-cloro-2-difluorometoxifenil pirazolopirimidina, composiciones y métodos de uso de los mismos.
CL2018001199A1 (es) Composiciones terapéuticas para el tratamiento del virus de inmunodeficiencia humana
EA201690556A1 (ru) Способы и фармацевтические композиции для лечения вызванных вирусом гепатита в инфекций
EA201790831A1 (ru) Противовирусное действие наразина в корме для свиней
BR112017015580A2 (pt) composição de limpeza para lavagem de louça, e, método para formar uma composição de limpeza para lavagem de louça
SG11201708659SA (en) Ternary compositions of methyl perfluoroheptene ethers and trans-1,2-dichloroethylene, and uses thereof
CL2017001615A1 (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2.
CL2017000674A1 (es) Método para alimentación de peces, método para la esmoltificación y la prevención de la desmoltificación de salmónidos, y para la profilaxis y tratamiento del síndrome hemorrágico del smolt (shs) en salmónidos
CU20170044A7 (es) Método mejorado para producir una composición de partículas enterovirales a través de la inactivación del enterovirus y la adsorción en coadyuvantes
PH12019500953A1 (en) Water soluble tomato extract protects against adverse effects of air pollution
CO2018001027A2 (es) Un proceso para tratar leche
EA201990998A1 (ru) Фармацевтические составы и способы их получения
EA201790415A1 (ru) ЛИОФИЛИЗИРОВАННЫЕ СОСТАВЫ ДЛЯ АНТИДОТА ФАКТОРА Xa
EA201790552A1 (ru) Применение элсиглутида для лечения мукозита желудочно-кишечного тракта, включая индуцированную химиотерапией диарею
CL2018000513A1 (es) Vacunas de pestivirus para temblores congénitos
GB2544439A (en) Antiviral composition
MX2020003473A (es) Nuevo inhibidor de proteina-cinasa-cinasa activada por mitogeno (mek) para el tratamiento de infecciones virales y bacterianas.
CL2018000253A1 (es) Respuesta inmunitaria potenciada de las especies porcinas
CL2017000560A1 (es) Fórmula que incluye glicopirrolato, método y sistema
BR112017028185A2 (pt) composições farmacêuticas sólidas para tratar hcv
CL2015000906A1 (es) Compuestos derivados de 1,3-oxazolidin-2-ona y 2-oxo-1,3-imidazolina, inhibidores del canal de potasio activado por calcio (kca3.1); composicion farmaceutica; metodo de tratamiento; y uso para el tratamiento o profilaxis de enfermedad renal poliquistica, asma, edema cerebral y enfermedad del intestino inflamatorio, entre otros.
BR112018000982A2 (pt) composições farmacêuticas sólidas para tratar hcv
MY188330A (en) Cleaning agent composition for glass hard disk substrate

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM